A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61P 31/00 (2006.01) A61P 31/18 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2542508
The invention relates to human or humanised, chimeric, monoclonal, class IgG3 antibodies produced in a cell line of rat myeloma, especially line YB2/0. Said antibodies have a strong phagocytosis activity and can be administered for the treatment of cancers and infections.
La présente invention se rapporte à des anticorps monoclonaux anti Rhesus D de classe IgG3 produits dans une lignée cellulaire de myélome de rat, la lignée YB2/0. Ces anticorps présentent une forte activité de phagocytose.
Bihoreau Nicolas
Bourel Dominique
de Romeuf Christophe
Jorieux Sylvie
Klein Philippe
Laboratoire Francais Du Fractionnement Et Des Biotechnologies
Lfb Biotechnologies
Smart & Biggar
LandOfFree
Novel igg3 antibodies for stimulating phagocytosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel igg3 antibodies for stimulating phagocytosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel igg3 antibodies for stimulating phagocytosis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1918862